Skip to main content
. 2022 Feb 10;14(2):392. doi: 10.3390/pharmaceutics14020392

Figure 4.

Figure 4

Figure 4

Cell viability of chicken fibroblasts (CEC-32 cell line) exposed to toltrazuril-loaded nanocapsules based on membrane damage (LIVE/DEAD® Viability/Cytotoxicity Kit) after (A) 24, (B) 48 and (C) 72 h. Data represent mean ± SD (n = 3−4). * p < 0.05 vs. C(−) (one-way ANOVA, post hoc Dunnett’s test). NCS100 = blank Eudragit® S100 nanocapsules; NCS100t = toltrazuril-loaded Eudragit® S100 nanocapsules; LNC = blank lipid core nanocapsules; LNCt = toltrazuril-loaded lipid core nanocapsules; C(+) = positive control; C(−) = negative control. Blank formulations (NCS100 and LNC) were added the same volume, respectively, to the drug-loaded nanoformulation.